Drug Database
H02AB09 hydrocortisone
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Alkindi 0.5 mg, 1 mg, 2 mg, and 5 mg granules in capsules for opening
- POM Hydrocortisone 10 mg Soluble Tablets
- POM Hydrocortisone 10 mg Tablets
- POM Hydrocortisone 10 mg Tablets
- POM Hydrocortisone 10 mg Tablets (Focus)
- POM Hydrocortisone 100 mg Powder for Solution for Injection or Infusion
- POM Hydrocortisone 100 mg Powder for Solution for Injection/Infusion
- POM Hydrocortisone 10mg Dispersible Tablets
- POM Hydrocortisone 10mg soluble tablets
- POM Hydrocortisone 10mg Soluble Tablets
- POM Hydrocortisone 10mg/5ml Oral Solution
- POM Hydrocortisone 20 mg Tablets
- POM Hydrocortisone 20 mg Tablets (Focus Pharmaceuticals)
- POM Hydrocortisone 20mg Dispersible Tablets
- POM Hydrocortisone 5mg Dispersible Tablets
- POM Hydrocortisone 5mg/5ml Oral Solution
- POM Hydrocortisone Solution for Injection
- POM Plenadren 20 mg modified-release tablets
- POM Plenadren 5 mg modified-release tablets
- POM Solu-Cortef
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).